chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Sinus headache
Clinical narrative: headache on right side of head and sinus drain; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 09Apr2021 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to iv dye. Concomitant medications included acetylsalicylic acid (ASPRIN) used for unknown indication from unspecified dates, unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 19Mar2021 at 11:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 10Apr2021 at 15:00, the patient experienced headache on right side of head and sinus drain. No therapeutic measures were taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event headache on right side of head and sinus drain was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Influenza like illness, Lymphadenopathy, Pain in extremity
Clinical narrative: flu symptoms; Extensive medium lymph swelling and mild aches from jab site on left bicep all around left shoulder and shoulder blade, to left clavicle.Other minor flu symptoms - tiredness.; mild aches from jab site; mild aches from jab site on left bicep all around left shoulder and shoulder blade, to left clavicle.; mild aches from jab site on left bicep all around left shoulder and shoulder blade, to left clavicle.; tiredness; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 24Mar2021 at 10:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included myocardial infarction with stent in December 2019, slightly elevated cholesterol levels and minor seasonal hay fever. Concomitant medications included atorvastatin calcium (ATORVASTATIN), acetylsalicylic acid (ASPIRIN) and paracetamol (ACETAMINOFEN); all from unknown date for unknown indication and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 25Mar2021 at 10:45, the patient experienced extensive medium lymph swelling and mild aches from jab site on left bicep all around left shoulder and shoulder blade, to left clavicle, minor flu symptoms and tiredness. Therapeutic measures were taken as a result of the adverse events and included treatment with acetaminophen (MANUFACTURER UNKNOWN) from unknown dates and unknown if ongoing. The clinical outcome of the events extensive medium lymph swelling and mild aches from jab site on left bicep all around left shoulder and shoulder blade, to left clavicle, minor flu symptoms and tiredness was recovering at the time of this report. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the arm left on 14Apr2021 (at the age of 63-year-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: flu symptoms; Extensive medium lymph swelling and mild aches from jab site on left bicep all around left shoulder and shoulder blade, to left clavicle.Other minor flu symptoms - tiredness.; mild aches from jab site; mild aches from jab site on left bicep all around left shoulder and shoulder blade, to left clavicle.; mild aches from jab site on left bicep all around left shoulder and shoulder blade, to left clavicle.; tiredness; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 24Mar2021 at 10:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included myocardial infarction with stent in December 2019, slightly elevated cholesterol levels and minor seasonal hay fever. Concomitant medications included atorvastatin calcium (ATORVASTATIN), acetylsalicylic acid (ASPIRIN) and paracetamol (ACETAMINOFEN); all from unknown date for unknown indication and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 25Mar2021 at 10:45, the patient experienced extensive medium lymph swelling and mild aches from jab site on left bicep all around left shoulder and shoulder blade, to left clavicle, minor flu symptoms and tiredness. Therapeutic measures were taken as a result of the adverse events and included treatment with acetaminophen (MANUFACTURER UNKNOWN) from unknown dates and unknown if ongoing. The clinical outcome of the events extensive medium lymph swelling and mild aches from jab site on left bicep all around left shoulder and shoulder blade, to left clavicle, minor flu symptoms and tiredness was recovering at the time of this report. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the arm left on 14Apr2021 (at the age of 63-year-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 73.0
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia
Clinical narrative: Pain inside the left bicep muscle; Pain in the joints near of the elbow; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old patient (unspecified gender) received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 17Mar2021 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included tendinosis in the wrist, arthritis, herniated disc (stenosis), COVID-19. The patient had no known allergies. Concomitant medications included cyclobenzaprine (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASPIRIN), vitamin d nos (VIT D) and MULTIV all from an unknown date and for unknown indication. The patient previously received the first dose of BNT162b2 (COMIRNATY; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Feb2021 at 12:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021, the patient experienced pain inside the left bicep muscle and in the joints near of the elbow. The patient reported that one month after the second dose and the pain continued. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of reported events. The clinical outcome of the events pain inside the left bicep muscle and in the joints near of the elbow was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Fatigue, Headache, Malaise
Clinical narrative: Felt dizzy like walking, used arms to focus on balance; Then joint pain in knees.; Very nauseous; Headache; Felt tired; Injection site hurt; 5-10 min after shot felt unwell. Can't articulate- not a feeling ever had.; This is a spontaneous report from a non-contactable consumer, the patient. A patient of unknown gender and unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 06Apr2021, as a single dose for COVID-19 immunisation. Medical history included known allergies to antibiotics and food sensitivities. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included losartan (MANUFACTURER UNKNOWN), amitriptyline (MANUFACTURER UNKNOWN) and other unspecified medication; all from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021, 5-10 minutes after shot, the patient felt unwell. The patient could not articulate the feeling as the patient had not a felt like that ever. The patient experienced joint pain in knees, wanted to use bathroom before leaving, felt dizzy like walking, used arms to focus on balance, was very nauseous during car ride to home. The patient felt tired once at home and had headache, joint pain and injection site hurt. 6 hours later, the patient ate dinner and felt better. On 14Apr2021, the patient experienced tiredness physically and mentally. On 15Apr2021, the patient awoke tired and remained very tired. Therapeutic measures were taken as a result of the events which included treatment with icing the site of vaccination and ibuprofen on 06Apr2021. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events joint pain in knees, injection site hurt, felt dizzy, nauseous, headache, tiredness and felt unwell was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Nausea, Vaccination site pain
Clinical narrative: Felt dizzy like walking, used arms to focus on balance; Then joint pain in knees.; Very nauseous; Headache; Felt tired; Injection site hurt; 5-10 min after shot felt unwell. Can't articulate- not a feeling ever had.; This is a spontaneous report from a non-contactable consumer, the patient. A patient of unknown gender and unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 06Apr2021, as a single dose for COVID-19 immunisation. Medical history included known allergies to antibiotics and food sensitivities. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included losartan (MANUFACTURER UNKNOWN), amitriptyline (MANUFACTURER UNKNOWN) and other unspecified medication; all from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021, 5-10 minutes after shot, the patient felt unwell. The patient could not articulate the feeling as the patient had not a felt like that ever. The patient experienced joint pain in knees, wanted to use bathroom before leaving, felt dizzy like walking, used arms to focus on balance, was very nauseous during car ride to home. The patient felt tired once at home and had headache, joint pain and injection site hurt. 6 hours later, the patient ate dinner and felt better. On 14Apr2021, the patient experienced tiredness physically and mentally. On 15Apr2021, the patient awoke tired and remained very tired. Therapeutic measures were taken as a result of the events which included treatment with icing the site of vaccination and ibuprofen on 06Apr2021. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events joint pain in knees, injection site hurt, felt dizzy, nauseous, headache, tiredness and felt unwell was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Neuralgia
Clinical narrative: Nerve pain and twitching in arm, upper left back, burning and pulling sensation. Diagnosed as Neuralgia by E.R.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the arm left on 09Apr2021 at 18:45 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included migraine, COVID-19 and allergy to quinolones. Concomitant medications were not reported. The patient previously took received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the arm left on 19Mar2021 at 12:30 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 20:30 the patient experienced Nerve pain and twitching in arm, upper left back, burning and pulling sensation and She was diagnosed as having Neuralgia by E.R. The event resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  Therapeutic measures were taken as a result of neuralgia and included treatment with (unspecified) pain medications, and muscle relaxers. The clinical outcome of the event Neuralgia was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Pyrexia
Clinical narrative: Tired; Feverish, 99; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 14Apr2021 at 08:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history and Concomitant medications were not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EPT534) via an unspecified route of administration in the right arm on 24Mar2021 at 09:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 08:00, the patient experienced tired, feverish 99. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. On 15Apr2021, the patient underwent Body temperature and the result was 99 (UNSPECIFIED UNITS). The clinical outcome of the events tired, feverish 99 was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: get swollen by my collar bone the whole top of my shoulder then noticed a ball inside; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0162) via an unspecified route of administration in the left arm on 03Apr2021 at 10:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not take any medications within two weeks of vaccination. The patient had no known allergies to medications, food, or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8730) via an unspecified route of administration in the left arm on 23Mar2021 at 13:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021, at 07:00 the patient started to get swollen by collar bone the whole top of shoulder then noticed a ball inside as well. Therapeutic measures were not taken as a result of the adverse event gets swollen by my collar bone the whole top of my shoulder then noticed a ball inside. The clinical outcome of the event started to get swollen by collar bone the whole top of shoulder then noticed a ball inside as well was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pyrexia
Clinical narrative: Headache; fever; exhaustion; This is a spontaneous report from a contactable consumer. A non-pregnant female patient of unspecified age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on 12Apr2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was unknown whether the patient receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021, the patient experienced headache, fever and exhaustion. Therapeutic measures were not taken as a result of the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events headache, fever and exhaustion was resolved on an unknown date in Apr2021.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever after injection; This is a spontaneous report from a non-contactable consumer. A female patient of an unknown age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On an unknown date, the patient experienced fever after injection. The clinical outcome of the event fever after injection was unknown at the time of the report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Blood count, Bronchitis, Chronic obstructive pulmonary disease, Cough, Feeling abnormal
Clinical narrative: COPD; Bronchitis; sick; feeling really bad; Swollen glands; Cough; lots of sputum; spitting up; This is a spontaneous report from a contactable consumer or other non-health care professional (Patient). A 77-years-old male patient received first dose of bnt162b2 (PFIZER-BIOTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: R8737, Expiration date: Unknown), via an unspecified route of administration, in Right Arm on 04Apr2021 (at the age of 77-years-old) as dose 1, single for Covid-19 immunization. The patient medical history included Arterial sclerosis, Atrial fibrillation, Pacemaker, two heart attacks, one way bypass all from an unknown date and unknown if ongoing, 5way bypass Done at Hospital from 1986 to an unknown date, walking pneumonia from Dec1969 to an unknown date Hospitalized. There patient concomitant medications were not reported. It was reported that the patient tried calling last Tuesday when he was really sick but the waiting was beyond him. On 04Apr2021 he got the shot and it was uneventful and he was just getting finished with a slight cough and he was basically done with it, he has COPD. 05Apr2021 he started feeling really bad, spitting up, coughing, lots of sputum, he could not sleep. he went to his doctor on 06Apr2021 and was given azithromycin and took that for 5 days and is in the last throws of bronchitis, he was just about done with it and totally cleared up. he takes care of his immune system. he has tremendous swollen glands by his carotid arteries and on the side of his neck under his chin. his mother died from Hodgkin disease and she woke up one morning and had very swollen glands and then got diagnosed with it. He was afraid he has cancer and it has been awakened from the vaccine. He was afraid that something that was dormant has been awaken, he wanted to know can the vaccine do that. The swollen glands are bulging. The patient never had a fever. The patient underwent lab tests and procedures which included blood count: looked great. The outcome for the events cough, lots of sputum, swollen glands was reported as not resolved and for remaining events outcome was reported as unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Gastrooesophageal reflux disease, Illness, Lymphadenopathy, Productive cough
Clinical narrative: COPD; Bronchitis; sick; feeling really bad; Swollen glands; Cough; lots of sputum; spitting up; This is a spontaneous report from a contactable consumer or other non-health care professional (Patient). A 77-years-old male patient received first dose of bnt162b2 (PFIZER-BIOTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: R8737, Expiration date: Unknown), via an unspecified route of administration, in Right Arm on 04Apr2021 (at the age of 77-years-old) as dose 1, single for Covid-19 immunization. The patient medical history included Arterial sclerosis, Atrial fibrillation, Pacemaker, two heart attacks, one way bypass all from an unknown date and unknown if ongoing, 5way bypass Done at Hospital from 1986 to an unknown date, walking pneumonia from Dec1969 to an unknown date Hospitalized. There patient concomitant medications were not reported. It was reported that the patient tried calling last Tuesday when he was really sick but the waiting was beyond him. On 04Apr2021 he got the shot and it was uneventful and he was just getting finished with a slight cough and he was basically done with it, he has COPD. 05Apr2021 he started feeling really bad, spitting up, coughing, lots of sputum, he could not sleep. he went to his doctor on 06Apr2021 and was given azithromycin and took that for 5 days and is in the last throws of bronchitis, he was just about done with it and totally cleared up. he takes care of his immune system. he has tremendous swollen glands by his carotid arteries and on the side of his neck under his chin. his mother died from Hodgkin disease and she woke up one morning and had very swollen glands and then got diagnosed with it. He was afraid he has cancer and it has been awakened from the vaccine. He was afraid that something that was dormant has been awaken, he wanted to know can the vaccine do that. The swollen glands are bulging. The patient never had a fever. The patient underwent lab tests and procedures which included blood count: looked great. The outcome for the events cough, lots of sputum, swollen glands was reported as not resolved and for remaining events outcome was reported as unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Myalgia, Nausea
Clinical narrative: muscle aches; chills; general fatigue; fever; nausea; lack of appetite; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm right on 13Apr2021 at 14:15 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not have allergies to medications, food, or other products. Concomitant medications included paracetamol (ACETAMINOPHEN), ibuprofen (MANUFACTURER UNKNOWN) and ascorbic acid, pyridoxine hydrochloride, biotin, folic acid, retinol, pantothenic acid, riboflavin, Phyto menadione, nicotinamide, beta-carotene, iron, magnesium, manganese, chromium, copper, zinc, calcium, iodine, selenium, vitamin d nos, vitamin b12 nos, xanthophyll, lycopene, vitamin b1 nos, vitamin e nos (CENTRUM WOMEN MULTIVIT) all were from unknown date and for unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm right on an unknown date in Mar2021 at 14:00 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 07:00, the patient experienced the events muscle aches, chills, general fatigue and progressed to fever, nausea, and lack of appetite throughout the day. The events did not result in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as the result of adverse events and included treatment with self-administered Ibuprofen and acetaminophen. The clinical outcome of the events muscle aches, chills, general, fever, nausea, and lack of appetite were recovered on 15Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: muscle aches; chills; general fatigue; fever; nausea; lack of appetite; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm right on 13Apr2021 at 14:15 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not have allergies to medications, food, or other products. Concomitant medications included paracetamol (ACETAMINOPHEN), ibuprofen (MANUFACTURER UNKNOWN) and ascorbic acid, pyridoxine hydrochloride, biotin, folic acid, retinol, pantothenic acid, riboflavin, Phyto menadione, nicotinamide, beta-carotene, iron, magnesium, manganese, chromium, copper, zinc, calcium, iodine, selenium, vitamin d nos, vitamin b12 nos, xanthophyll, lycopene, vitamin b1 nos, vitamin e nos (CENTRUM WOMEN MULTIVIT) all were from unknown date and for unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm right on an unknown date in Mar2021 at 14:00 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 07:00, the patient experienced the events muscle aches, chills, general fatigue and progressed to fever, nausea, and lack of appetite throughout the day. The events did not result in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as the result of adverse events and included treatment with self-administered Ibuprofen and acetaminophen. The clinical outcome of the events muscle aches, chills, general, fever, nausea, and lack of appetite were recovered on 15Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Tongue discomfort
Clinical narrative: Metallic taste in mouth within 5 minutes; Tongue burns at tip after eating solid food; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 15Apr2021 at 11:30 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history included coronary artery disease, blood pressure high, high cholesterol and obesity. The patient had unspecified known allergies. The patient has taken unspecified concomitant medications. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 18Mar2021 at 11:30 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 11:35 (within 5 minutes), the patient experienced metallic taste in mouth. On 15Apr2021, the patient tongue burned at tip after eating solid food. Even 3 hours later and issues continued. Therapeutic measures were not taken as a result of these events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events metallic taste and tongue burns was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Decreased appetite, Dysgeusia, Fatigue
Clinical narrative: Stuffed nose; Joint soreness on various parts of body; Muscle soreness on various parts of body; Fatigue; Metallic taste and smell; Metallic taste and smell; Loss of appetite; Nite sweats; Hot flashes; Minor headache; Weakness; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 14Apr2021 at 15:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included anemia. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ascorbic acid (VITAMIN C), iron (MANUFACTURER UNKNOWN), zinc (MANUFACTURER UNKNOWN), sambucus nigra fruit (ELDERBERRY) and probiotics (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 23Mar2021 at 18:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 22:00, the patient experienced stuffed nose, joint/muscle soreness on various parts of the body, fatigue, metallic taste and smell, loss of appetite, nite sweats, hot flashes, minor headache, and weakness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events stuffed nose, joint/muscle soreness on various parts of the body, fatigue, metallic taste and smell, loss of appetite, nite sweats, hot flashes, minor headache, and weakness was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hot flush, Myalgia, Nasal discomfort, Night sweats
Clinical narrative: Stuffed nose; Joint soreness on various parts of body; Muscle soreness on various parts of body; Fatigue; Metallic taste and smell; Metallic taste and smell; Loss of appetite; Nite sweats; Hot flashes; Minor headache; Weakness; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 14Apr2021 at 15:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included anemia. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ascorbic acid (VITAMIN C), iron (MANUFACTURER UNKNOWN), zinc (MANUFACTURER UNKNOWN), sambucus nigra fruit (ELDERBERRY) and probiotics (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 23Mar2021 at 18:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 22:00, the patient experienced stuffed nose, joint/muscle soreness on various parts of the body, fatigue, metallic taste and smell, loss of appetite, nite sweats, hot flashes, minor headache, and weakness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events stuffed nose, joint/muscle soreness on various parts of the body, fatigue, metallic taste and smell, loss of appetite, nite sweats, hot flashes, minor headache, and weakness was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Parosmia
Clinical narrative: Stuffed nose; Joint soreness on various parts of body; Muscle soreness on various parts of body; Fatigue; Metallic taste and smell; Metallic taste and smell; Loss of appetite; Nite sweats; Hot flashes; Minor headache; Weakness; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 14Apr2021 at 15:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included anemia. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ascorbic acid (VITAMIN C), iron (MANUFACTURER UNKNOWN), zinc (MANUFACTURER UNKNOWN), sambucus nigra fruit (ELDERBERRY) and probiotics (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 23Mar2021 at 18:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 22:00, the patient experienced stuffed nose, joint/muscle soreness on various parts of the body, fatigue, metallic taste and smell, loss of appetite, nite sweats, hot flashes, minor headache, and weakness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events stuffed nose, joint/muscle soreness on various parts of the body, fatigue, metallic taste and smell, loss of appetite, nite sweats, hot flashes, minor headache, and weakness was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Discomfort, Initial insomnia, Pain, Testicular pain, Testicular swelling
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 37-year-old male patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# ER8733), at the age of 37, via an unspecified route of administration, left arm, on Apr 14, 2021, at 13:00, single dose, for COVID-19 immunisation. The patient has no reported medical history. The patient has no known allergies according to his knowledge. The patient didn't receive other medications in two-weeks. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EN6207), at the age of 37, via an unspecified route of administration, left arm, on Mar 24, 2021, at 13:00, single dose, for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On Apr 14, 2021, the events started at 13:00 and were mild until 23:00; at this time patient experienced very uncomfortable testicular pain. He also had pain in surrounding groin area. His testicles became very swollen and pulsed with pain, which made it impossible to fall asleep. Reportedly, patient took medication, which seemed to help and reduced swelling in right testicle first. Then started reducing in left testicle approximately 15 minutes later, and he was able to fall asleep at 3:30 am. When patient woke swelling was mostly reduced. Only slight pain and discomfort still existed. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures taken as a result of events and included treatment with ibuprofen 600mg on Apr 15, 2021, at 03:00. The clinical outcome of uncomfortable testicular pain, pain in surrounding groin area, testicles became very swollen, impossible to fall asleep and discomfort were resolving at the time of this report. No follow-up attempts needed. No further information expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Anisomastia, Breast discomfort, Breast enlargement, Breast swelling, Capsular contracture associated with breast implant
Clinical narrative: breasts look lopsided.; extremely uncomfortable; could barely sleep; left breast firm, tight; Aggressive capsular contracture of breast implant; left breast firm, tight, and swollen.; breast got progressively larger, firmer, tighter, and more uncomfortable.; a cyst-like bump between  left arm pit and bicep; This is a spontaneous report from a contactable other healthcare professional, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199) via an unspecified route of administration in the left arm on 18Mar2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Concomitant medication included unspecified medications for birth control taken from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6200) via an unspecified route of administration in the left arm on 25Feb2021 (at the age of 36-years-old) as a single dose COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Mar2021, the patient noticed a cyst-like bump between her left arm pit and bicep. It gradually had gotten smaller since then and at the time of this report it was very tiny but was still there. On 05Apr2021, the patient experienced sudden/ aggressive capsular contracture of breast implant and noticed left breast felt firm, tight, and swollen. No discomfort but it felt different. Her two breasts were not visibly different at this time. Each day for the next 5 days after this her left breast got progressively larger, firmer, tighter, and more uncomfortable. On 10April2021, the patient could barely sleep because left breast felt so uncomfortable. It looked significantly different and her two breasts look lopsided. The left breast was pushed up very high and looked huge compared to the right. She was extremely uncomfortable and only way to fix that may be surgery. Surgeon said he had never seen a case come on as sudden and "impressive" as this. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with SINGULAIR from 08Apr2021. The clinical outcome of the event a cyst-like bump between left arm pit and bicep, aggressive capsular contracture of breast implant, left breast firm, tight, and swollen and more uncomfortable, breasts look lopsided, extremely uncomfortable and could barely sleep were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Limb mass, Poor quality sleep
Clinical narrative: breasts look lopsided.; extremely uncomfortable; could barely sleep; left breast firm, tight; Aggressive capsular contracture of breast implant; left breast firm, tight, and swollen.; breast got progressively larger, firmer, tighter, and more uncomfortable.; a cyst-like bump between  left arm pit and bicep; This is a spontaneous report from a contactable other healthcare professional, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199) via an unspecified route of administration in the left arm on 18Mar2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Concomitant medication included unspecified medications for birth control taken from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6200) via an unspecified route of administration in the left arm on 25Feb2021 (at the age of 36-years-old) as a single dose COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Mar2021, the patient noticed a cyst-like bump between her left arm pit and bicep. It gradually had gotten smaller since then and at the time of this report it was very tiny but was still there. On 05Apr2021, the patient experienced sudden/ aggressive capsular contracture of breast implant and noticed left breast felt firm, tight, and swollen. No discomfort but it felt different. Her two breasts were not visibly different at this time. Each day for the next 5 days after this her left breast got progressively larger, firmer, tighter, and more uncomfortable. On 10April2021, the patient could barely sleep because left breast felt so uncomfortable. It looked significantly different and her two breasts look lopsided. The left breast was pushed up very high and looked huge compared to the right. She was extremely uncomfortable and only way to fix that may be surgery. Surgeon said he had never seen a case come on as sudden and "impressive" as this. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with SINGULAIR from 08Apr2021. The clinical outcome of the event a cyst-like bump between left arm pit and bicep, aggressive capsular contracture of breast implant, left breast firm, tight, and swollen and more uncomfortable, breasts look lopsided, extremely uncomfortable and could barely sleep were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Thirst
Clinical narrative: Slight headache; became very thirsty around 1pm; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 15Apr2021 at 07:30 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included iron deficiency started on unspecified date in 2020 and stopped on unspecified date in 2021. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the right arm on 25Mar2021 at 07:30 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. On 15Apr2021 around 13:00 the patient became very thirsty. On 15Apr2021 at 13:30 the patient had a slight headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the event slight headache which included Advil tablet. No therapeutic measures were taken as a result of the adverse event headache. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very thirsty and slight headache was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.